Acadia Pharmaceuticals 2021 Annual Meeting Notice

Acadia Pharmaceuticals Inc. proxy statement and notice for the 2021 Annual Meeting of Stockholders scheduled for June 22, 2021. The meeting agenda includes election of three Class II directors, advisory vote on executive compensation, and ratification of Ernst & Young LLP as independent auditor.